Journal of Shanghai Jiao Tong University (Medical Science) >

2019 , Vol. 39 >Issue 3: 221

DOI: https://doi.org/10.3969/j.issn.1674-8115.2019.03.001

Outstanding international article

EGFR and ERBB germline mutations expected to become new therapeutic targets for lung cancer patients

  • The research group of LU Shun
Expand

Online published: 2019-04-28

Fold

Cite this article

The research group of LU Shun . EGFR and ERBB germline mutations expected to become new therapeutic targets for lung cancer patients[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2019 , 39(3) : 221 . DOI: 10.3969/j.issn.1674-8115.2019.03.001

Options
Outlines

/

〈 〉